Intestinal bacteria are potential biomarkers and therapeutic targets for gastric cancer

Shili Liu,Jianjian Dai,Xiang Lan,Bingbing Fan,Tianyi Dong,Ying Zhang,Mingyong Han
DOI: https://doi.org/10.1016/j.micpath.2021.104747
IF: 3.848
2021-02-01
Microbial Pathogenesis
Abstract:<p>The diagnostic and therapeutic role of intestinal microbiota in gastric carcinogenesis remains unclear. In this study, feces from gastric cancer patients and healthy people were sequenced for microbiota analysis, and the correlation between fecal bacteria and the occurrence of gastric cancer was explored. The β-diversity results showed that microbial compositions varied between gastric cancer patients and healthy people. Interestingly, the dissection of microbial structure revealed that all facultative anaerobic genera with relatively high abundances expanded significantly in gastric cancer patients. The succeeding correlation analysis demonstrated a distorted interaction of intestinal bacteria in gastric cancer. The application of some differential bacteria, <em>Desulfovibrio, Escherichia, Faecalibacterium</em> or <em>Oscillospira</em>, as biomarkers to predict gastric cancer could all reach an accuracy of 0.900 or above. The shift in <em>Desulfovibrio</em> was specifically verified by qPCR in newly collected fecal samples, and the patients with stage IV gastric cancer were identified to have significantly more <em>Desulfovibrio</em> than those with stage I, II and III gastric cancer. The possible role of <em>Desulfovibrio</em> in gastric cancer was assessed with H<sub>2</sub>S-treated HT-29 cells, and the results showed that H<sub>2</sub>S induced NO, IL-1β and IL-18 production, which is important for inflammation promotion and can be delivered through the bloodstream. This study suggests a correlation of intestinal microbiota and the development of gastric cancer.</p>
immunology,microbiology
What problem does this paper attempt to address?